Lindenwold Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,557
Closed -$223K 117
2022
Q3
$223K Buy
2,557
+70
+3% +$7.35K 0.17% 101
2022
Q2
$283K Buy
2,487
+10
+0.4% +$1.15K 0.2% 92
2022
Q1
$321K Buy
2,477
+390
+19% +$56.2K 0.2% 92
2021
Q4
$377K Buy
+2,087
New +$362K 0.22% 86

Other funds holding OMCL

Lindenwold Advisors's OMCL Position: Q4 2022 in Review

Lindenwold Advisors sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 2,557 shares — an estimated $223K sold.

Lindenwold Advisors first reported a position in OMCL in Q4 2021 and held it in 4 quarters. The position peaked at $377K in Q4 2021. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Lindenwold Advisors reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Lindenwold Advisors sold 2,557 Omnicell shares in Q4 2022, an estimated $223K.
  • Lindenwold Advisors first reported a position in Omnicell in Q4 2021 and held it in 4 quarters.
  • Lindenwold Advisors's Omnicell position peaked at $377K in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Lindenwold Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.